Aşılar

Vaccines fall into several categories based on antigen delivery. Live attenuated vaccines contain weakened pathogens that replicate without causing illness, like MMR. Inactivated vaccines use pathogens killed by heat or chemicals, such as rabies vaccine. Subunit vaccines deliver only specific pathogen components, like hepatitis B's viral surface proteins. Toxoid vaccines use inactivated bacterial toxins, exemplified by tetanus vaccine. Modern mRNA vaccines, like COVID-19 vaccines, deliver genetic instructions directing host cells to produce viral antigens.

mRNA vaccines deliver synthetic genetic instructions into host cells, which then produce the viral spike protein as the antigen. This intracellularly generated protein triggers the immune system without requiring actual viral particles. The produced antigen is presented via MHC molecules to immune cells, promoting both antibody production and cellular immunity. This approach enables rapid vaccine development and avoids the need to culture or inactivate pathogens.

Antigens are foreign substances that the immune system recognizes and targets. Vaccines expose immune cells to antigens derived from whole pathogens or selected pathogen parts, training the immune system to build protection against disease. Antigen-presenting cells process these antigens and display them on cell surfaces via MHC molecules, activating helper T cells and B cells. This antigen recognition initiates both antibody production and the formation of long-lasting memory cells.

Immunological memory develops when activated B and T cells differentiate into memory cells that persist long-term in the host. Upon re-exposure to the pathogen, these memory cells rapidly expand and mount a robust immune response, often reducing disease severity or preventing illness entirely. Live attenuated vaccines typically provide lifelong immunity with a single dose, while inactivated vaccines often require booster shots to maintain protection over time.

Vaccines are among the most effective preventive medicine tools, designed to prepare the immune system to recognize and combat infectious agents before natural exposure occurs. By stimulating an adaptive immune response, vaccines reduce the incidence and severity of infectious diseases and their occurrence in populations. This proactive approach prevents illness and reduces transmission, making vaccines critical for public health and disease control strategies.

Vaccine-stimulated B cells differentiate into plasma cells that secrete antigen-specific antibodies. These antibodies neutralize pathogens, opsonize them for phagocytosis by immune cells, or activate the complement system to destroy pathogens. Additionally, CD8+ cytotoxic T cells eliminate infected cells by inducing apoptosis, particularly important for intracellular pathogens. This multi-faceted antibody and cellular response provides comprehensive protection against disease.

Live attenuated vaccines contain weakened pathogens that replicate in the host, generating a strong immune response and typically providing lifelong immunity with a single dose. Inactivated vaccines use killed pathogens that cannot replicate, producing a weaker initial response that wanes over time, necessitating booster shots to maintain protective antibody levels. Booster shots reactivate memory cells and restore immunity to protective levels.